Annual Current Liabilities
$10.73 M
-$1.13 M-9.49%
01 December 2023
Summary:
Plus Therapeutics annual total current liabilities is currently $10.73 million, with the most recent change of -$1.13 million (-9.49%) on 01 December 2023. During the last 3 years, it has risen by +$2.19 million (+25.62%). PSTV annual current liabilities is now -41.75% below its all-time high of $18.41 million, reached on 31 December 2017.PSTV Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$12.11 M
-$6.67 M-35.53%
01 September 2024
Summary:
Plus Therapeutics quarterly total current liabilities is currently $12.11 million, with the most recent change of -$6.67 million (-35.53%) on 01 September 2024. Over the past year, it has increased by +$1.39 million (+12.91%). PSTV quarterly current liabilities is now -35.53% below its all-time high of $18.79 million, reached on 01 June 2024.PSTV Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +12.9% |
| 3 y3 years | +25.6% | +27.7% |
| 5 y5 years | -38.9% | -16.1% |
PSTV Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -9.5% | +82.7% | -35.5% | +146.1% |
| 5 y | 5 years | -38.9% | +82.7% | -35.5% | +146.1% |
| alltime | all time | -41.8% | +625.3% | -35.5% | +698.4% |
Plus Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $12.11 M(-35.5%) |
| June 2024 | - | $18.79 M(+80.7%) |
| Mar 2024 | - | $10.40 M(-3.1%) |
| Dec 2023 | $10.73 M(-9.5%) | $10.73 M(+1.8%) |
| Sept 2023 | - | $10.54 M(-7.6%) |
| June 2023 | - | $11.40 M(-10.9%) |
| Mar 2023 | - | $12.80 M(+8.0%) |
| Dec 2022 | $11.85 M(+101.9%) | $11.85 M(+59.7%) |
| Sept 2022 | - | $7.42 M(+6.4%) |
| June 2022 | - | $6.97 M(+41.7%) |
| Mar 2022 | - | $4.92 M(-16.2%) |
| Dec 2021 | $5.87 M(-31.3%) | $5.87 M(-38.1%) |
| Sept 2021 | - | $9.49 M(+13.6%) |
| June 2021 | - | $8.35 M(+0.5%) |
| Mar 2021 | - | $8.31 M(-2.6%) |
| Dec 2020 | $8.54 M(-41.1%) | $8.54 M(+1.6%) |
| Sept 2020 | - | $8.40 M(-14.0%) |
| June 2020 | - | $9.77 M(-34.8%) |
| Mar 2020 | - | $14.99 M(+3.5%) |
| Dec 2019 | $14.49 M(-17.5%) | $14.49 M(+0.4%) |
| Sept 2019 | - | $14.43 M(+3.6%) |
| June 2019 | - | $13.92 M(-23.9%) |
| Mar 2019 | - | $18.30 M(+4.2%) |
| Dec 2018 | $17.56 M(-4.6%) | $17.56 M(-0.5%) |
| Sept 2018 | - | $17.65 M(+0.2%) |
| June 2018 | - | $17.62 M(-1.5%) |
| Mar 2018 | - | $17.88 M(-2.9%) |
| Dec 2017 | $18.41 M(+47.3%) | $18.41 M(+0.1%) |
| Sept 2017 | - | $18.40 M(+39.1%) |
| June 2017 | - | $13.23 M(+2.7%) |
| Mar 2017 | - | $12.88 M(+3.0%) |
| Dec 2016 | $12.50 M(+48.2%) | $12.50 M(+14.6%) |
| Sept 2016 | - | $10.90 M(+8.2%) |
| June 2016 | - | $10.08 M(+4.1%) |
| Mar 2016 | - | $9.68 M(+14.8%) |
| Dec 2015 | $8.44 M(-47.0%) | $8.44 M(-10.7%) |
| Sept 2015 | - | $9.45 M(+2.5%) |
| June 2015 | - | $9.22 M(-50.7%) |
| Mar 2015 | - | $18.70 M(+17.5%) |
| Dec 2014 | $15.92 M(+6.8%) | $15.92 M(+9.9%) |
| Sept 2014 | - | $14.48 M(-13.5%) |
| June 2014 | - | $16.73 M(+12.9%) |
| Mar 2014 | - | $14.82 M(-0.5%) |
| Dec 2013 | $14.91 M(-15.4%) | $14.91 M(+17.9%) |
| Sept 2013 | - | $12.64 M(+61.2%) |
| June 2013 | - | $7.84 M(-53.0%) |
| Mar 2013 | - | $16.68 M(-5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $17.61 M(+125.2%) | $17.61 M(+14.7%) |
| Sept 2012 | - | $15.36 M(+23.8%) |
| June 2012 | - | $12.40 M(+13.2%) |
| Mar 2012 | - | $10.96 M(+40.1%) |
| Dec 2011 | $7.82 M(-40.9%) | $7.82 M(+21.4%) |
| Sept 2011 | - | $6.44 M(-58.7%) |
| June 2011 | - | $15.61 M(+6.6%) |
| Mar 2011 | - | $14.64 M(+10.7%) |
| Dec 2010 | $13.22 M(+61.6%) | $13.22 M(+37.5%) |
| Sept 2010 | - | $9.62 M(+33.0%) |
| June 2010 | - | $7.23 M(+1.6%) |
| Mar 2010 | - | $7.11 M(-13.1%) |
| Dec 2009 | $8.18 M(+14.7%) | $8.18 M(+23.4%) |
| Sept 2009 | - | $6.63 M(+2.4%) |
| June 2009 | - | $6.48 M(-6.0%) |
| Mar 2009 | - | $6.89 M(-3.4%) |
| Dec 2008 | $7.13 M(-11.6%) | $7.13 M(+2.0%) |
| Sept 2008 | - | $7.00 M(-4.4%) |
| June 2008 | - | $7.32 M(+0.2%) |
| Mar 2008 | - | $7.31 M(-9.4%) |
| Dec 2007 | $8.07 M(+22.5%) | $8.07 M(+44.3%) |
| Sept 2007 | - | $5.59 M(-0.1%) |
| June 2007 | - | $5.60 M(-6.8%) |
| Mar 2007 | - | $6.01 M(-8.8%) |
| Dec 2006 | $6.59 M(-7.0%) | $6.59 M(+14.8%) |
| Sept 2006 | - | $5.74 M(+10.3%) |
| June 2006 | - | $5.20 M(-19.8%) |
| Mar 2006 | - | $6.48 M(-8.4%) |
| Dec 2005 | $7.08 M(+116.7%) | $7.08 M(+51.8%) |
| Sept 2005 | - | $4.66 M(+43.0%) |
| June 2005 | - | $3.26 M(+0.8%) |
| Mar 2005 | - | $3.23 M(-1.0%) |
| Dec 2004 | $3.27 M(-27.1%) | $3.27 M(+1.9%) |
| Sept 2004 | - | $3.21 M(-3.2%) |
| June 2004 | - | $3.31 M(-0.3%) |
| Mar 2004 | - | $3.32 M(-25.9%) |
| Dec 2003 | $4.48 M(+53.0%) | $4.48 M(+6.5%) |
| Sept 2003 | - | $4.21 M(+74.0%) |
| June 2003 | - | $2.42 M(+9.5%) |
| Mar 2003 | - | $2.21 M(-24.6%) |
| Dec 2002 | $2.93 M(+60.1%) | $2.93 M(+8.3%) |
| Sept 2002 | - | $2.71 M(+42.3%) |
| June 2002 | - | $1.90 M(+0.2%) |
| Mar 2002 | - | $1.90 M(+3.6%) |
| Dec 2001 | $1.83 M(+23.8%) | $1.83 M(+20.7%) |
| Sept 2001 | - | $1.52 M(-1.6%) |
| June 2001 | - | $1.54 M |
| Dec 2000 | $1.48 M | - |
FAQ
- What is Plus Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Plus Therapeutics?
- What is Plus Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Plus Therapeutics?
- What is Plus Therapeutics quarterly current liabilities year-on-year change?
What is Plus Therapeutics annual total current liabilities?
The current annual current liabilities of PSTV is $10.73 M
What is the all time high annual current liabilities for Plus Therapeutics?
Plus Therapeutics all-time high annual total current liabilities is $18.41 M
What is Plus Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of PSTV is $12.11 M
What is the all time high quarterly current liabilities for Plus Therapeutics?
Plus Therapeutics all-time high quarterly total current liabilities is $18.79 M
What is Plus Therapeutics quarterly current liabilities year-on-year change?
Over the past year, PSTV quarterly total current liabilities has changed by +$1.39 M (+12.91%)